MedTrace Logo

Short Course Low Dose Oral Colchicine After ST Elevation Myocardial Infarction(STEMI)

NCT06020300 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2023-08-31

No results posted yet for this study

Summary

To Study Efficacy and safety oral colchicine 0.6 mg post ST Elevation myocardial infraction (STEMI)

Conditions

  • STEMI

Interventions

DRUG

Oral Colchicine 0.6 mg

Anti-Inflammatory Effects

DRUG

Oral Pyridoxine 10 mg

Colchicine look alike placebo

Sponsors & Collaborators

  • National University of Malaysia

    lead OTHER

Principal Investigators

  • HAMAT HAMDI, MBBchBAO · Head of Cardiology Unit

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-28
Primary Completion
2023-12-29
Completion
2024-05-31

Countries

  • Malaysia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06020300 on ClinicalTrials.gov